Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy
characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and …

Thrombotic thrombocytopenic purpura (TTP; also known as Moschcowitz disease) is
characterized by the concomitant occurrence of often severe thrombocytopenia …

Thrombotic thrombocytopenia purpura (TTP) is a rare, life-threatening disease with an
incidence of approximately 2 persons per million per year. It is characterized by severe …

Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is
characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal …

Severe ADAMTS13 deficiency occurs in 13% to 75% of thrombotic microangiopathies
(TMA). In this context, the early identification of a severe, antibody-mediated, ADAMTS13 …

Thrombotic thrombocytopenic purpura (TTP) is an acute, rare, life‐threatening disorder. This
report presents the South East (SE) England registry for TTP, from April 2002 to December …

Thrombotic thrombocytopenic purpura (TTP) is a life‐threatening disorder and plasma
exchange (PEX) remains the primary treatment modality. Twenty‐five patients with acute …

BACKGROUND: From 20 to 50% of patients who survive an acute episode of the acquired
form of thrombotic thrombocytopenic purpura relapse but clinical and laboratory markers of …

Recently, we showed that ADAMTS13 circulates in an open conformation during the acute
phase of immune-mediated thrombotic thrombocytopenic purpura (iTTP). Although the …

Immune-mediated thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder
caused by antibodies against ADAMTS13. From the United Kingdom TTP registry, we …